About the Product

Description


Etoscrib Plus Tablet containing Etoricoxib, Thiocolchicoside, and Paracetamol is used for the management of pain and muscle spasm. It helps in reducing inflammation, relieving pain, and improving mobility in musculoskeletal conditions.

Etoricoxib acts as an anti-inflammatory agent to reduce pain and swelling, Thiocolchicoside works as a muscle relaxant to relieve stiffness and spasms, and Paracetamol provides additional analgesic support for effective pain control.

The tablet is widely prescribed in orthopedic and general practice for conditions like back pain, joint pain, and muscle stiffness, leading to high demand and consistent repeat prescriptions.

With increasing cases of lifestyle-related pain and orthopedic issues, this product offers excellent business potential for retailers and distributors. Its fast relief profile, high prescription rate, and strong market demand make it a fast-moving product that can drive consistent sales and growth in the pain management segment.

Some patients may experience nausea, gastritis, dizziness, headache, or drowsiness. Rarely, serious side effects such as gastrointestinal irritation, liver enzyme elevation, or allergic reactions may occur and require medical attention.

Etoscrib Plus Tablet is indicated for the management of acute musculoskeletal pain, muscle spasms, low back pain, cervical pain, and conditions like osteoarthritis or spondylitis. It helps reduce inflammation, relieve muscle stiffness, and alleviate pain, thereby improving movement and daily functioning.

This medicine should be taken under medical supervision. Patients with a history of heart disease, gastrointestinal issues, liver disorders, or those taking other medications should consult their healthcare provider before use. Avoid alcohol consumption and do not exceed the recommended dose.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Etoscrib Plus Tablet in the PCD pharma franchise market?

Etoscrib Plus Tablet, containing Etoricoxib 60mg, Thiocolchicoside 4mg, and Paracetamol 325mg, has strong demand in the pain management and orthopedic segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand their musculoskeletal care portfolio.

Why should medical distributors include Etoscrib Plus Tablet in their product range?

Medical distributors and agencies can benefit from the consistent market demand for medicines used in acute pain, muscle spasm, arthritis, back pain, and orthopedic conditions. Etoscrib Plus Tablet helps strengthen a comprehensive pain and musculoskeletal care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Etoscrib Plus Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Etoscrib Plus Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Etoscrib Plus Tablet distribution?

Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted pain management and orthopedic product range when partnering for Etoscrib Plus Tablet distribution.

How can I become a distributor or franchise partner for Etoscrib Plus Tablet?

Medical distributors, stockists, and wholesalers interested in Etoscrib Plus Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.